FDA opens up review into hand disinfectants

There is a vast array of different products on the market. Few are manufactured and sold specifically for pharmaceuticals; most are developed for the healthcare sector and sold across both healthcare and pharmaceuticals. Generally, given the similarity in disinfectant efficacy testing standards, the cross use of such products is not problematic with the exception that products used in higher grade pharmaceutical cleanrooms need to be sterile. Although many products are available, the US Food and Drug Administration (FDA) is concerned about their effectiveness and the federal agency has opened a review in relation to healthcare use.

Because of the cross marketing and limited range of active ingredients in such products, this review will cut across the pharmaceutical sector. The use of hand disinfectants embraces a number of GMP concerns.

In light of this, Tim Sandle has written an article about the review and the implications for the pharmaceutical sector. The article is published in the GMP Review.

The reference is:

Sandle, T. (2015) FDA opens up review into hand disinfectants, GMP Review, 14 (2): 8-9

If you would like to review a copy, please contact Tim Sandle

Posted by Tim Sandle